home / stock / rgrx / rgrx quote
Last: | $0.0014 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.0014 |
High: | $0 |
Low: | $0 |
Volume: | 15 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0014 | $0 | $0.0014 | $0 | $0 | 15 | 04-19-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 241 | 04-17-2024 |
$0.0522 | $0 | $0.0522 | $0 | $0 | 83 | 04-15-2024 |
$0.0522 | $0.0522 | $0.0522 | $0.0522 | $0.0522 | 150 | 04-10-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 10 | 04-09-2024 |
$0.0014 | $0 | $0.0014 | $0 | $0 | 65 | 04-04-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 160 | 04-02-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 100 | 03-29-2024 |
$0.0014 | $0.0014 | $0.0014 | $0.0014 | $0.0014 | 100 | 03-28-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 70 | 03-26-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 20 | 03-25-2024 |
$0.0012 | $0.0012 | $0.0012 | $0.0012 | $0.0012 | 2,184 | 03-20-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 2 | 03-18-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 90 | 03-13-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 80 | 03-12-2024 |
$0.0012 | $0.0012 | $0.0012 | $0.0012 | $0.0012 | 1,812 | 03-11-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 45 | 03-07-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 45 | 03-06-2024 |
$0.0012 | $0.0012 | $0.0012 | $0.0012 | $0.0012 | 1,213 | 03-05-2024 |
$0.0012 | $0 | $0.0012 | $0 | $0 | 81 | 02-26-2024 |
News, Short Squeeze, Breakout and More Instantly...
Regenerx Biopharms Inc Company Name:
RGRX Stock Symbol:
OTCMKTS Market:
RegeneRx Effects Reverse Stock Split and Terminates SEC Reporting Obligations PR Newswire ROCKVILLE, Md. , Aug. 15, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("RegeneRx" or the "Company") , a clinical-stage drug development compa...
RegeneRx Receives Stockholder Approval for Reverse Stock Split PR Newswire ROCKVILLE, Md. , Aug. 7, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("RegeneRx" or the "Company") , a clinical-stage drug development company focused o...
RegeneRx To Extend Consent Solicitation Vote PR Newswire ROCKVILLE, Md. , Aug. 1, 2023 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("RegeneRx" or "Company"), a clinical-stage drug development company focused on tissue protection, repair, and...